Nutrien NTR
$63.84 −$1.57 (-2.40%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $64.54 +1.10%
Open$65.00
Prev close$65.41
Day range$63.81 – $66.15
Volume2.23M
Market cap$30.27B
P/E (TTM)13.9
Dividend yield3.44%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$6.06B+0.9% YoY
Operating profit$740.00M-15.6% YoY
Net profit$288.00M-38.6% YoY
Diluted EPS$0.60-37.5% YoY
Free cash flow-$950.00M+0.6% YoY
Operating cash flow-$425.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin30.6%
Operating margin14.2%
Net margin7.8%
Return on equity8.7%
Return on assets4.2%
Return on invested capital7.0%
Current ratio1.41
Liabilities / assets51.1%
Cash & investments$919.00M
Total debt$13.77B
Net cash (debt)-$12.85B
Free cash flow / sales7.4%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $6.06B | $10.81B | $6.05B | $26.89B | $5.34B |
| Total Operating Revenue | $6.06B | $10.81B | $6.05B | $26.89B | $5.34B |
| Cost of Revenue | $4.20B | $7.56B | $4.40B | $18.54B | $3.45B |
| Gross Profit | $1.86B | $3.25B | $1.65B | $8.35B | $1.89B |
| Operating Expense | $1.12B | $1.26B | $1.14B | $4.48B | $1.12B |
| Selling and Admin Expenses | $1.05B | $1.14B | $1.08B | $4.10B | $1.03B |
| -Selling & Marketing Expense | $811.00M | $1.00B | $799.00M | $3.32B | $817.00M |
| -General & Admin Expense | $238.00M | $140.00M | $278.00M | $784.00M | $208.00M |
| Other Taxes | $113.00M | $110.00M | $90.00M | $372.00M | $83.00M |
| Other Operating Expenses | -$42.00M | $11.00M | -$28.00M | $2.00M | $9.00M |
| Operating Profit | $740.00M | $1.99B | $507.00M | $3.87B | $771.00M |
| Net Non-Operating Interest Income (Expense) | -$178.00M | -$173.00M | -$176.00M | -$687.00M | -$183.00M |
| Non-Operating Interest Expense | $178.00M | $173.00M | $176.00M | $729.00M | $225.00M |
| Other Income (Expense) | -$79.00M | -$212.00M | -$147.00M | -$133.00M | $150.00M |
| Gain on Sale of Security | -$5.00M | -$13.00M | -$3.00M | -$9.00M | $9.00M |
| Earnings from Equity Interest | $0.00 | $4.00M | -$5.00M | $37.00M | $1.00M |
| Special Income (Charges) | -$11.00M | -$100.00M | -$61.00M | $149.00M | $260.00M |
| -Less:Restructuring and Mergern & Acquisition | -$29.00M | $66.00M | $16.00M | $68.00M | $46.00M |
| -Less:Write Off | $17.00M | $34.00M | $45.00M | $85.00M | -$3.00M |
| -Gain on Sale Of Business | -$23.00M | – | – | $301.00M | $302.00M |
| Other Non-Operating Income (Expenses) | -$63.00M | -$103.00M | -$78.00M | -$310.00M | -$120.00M |
| Pretax Profit | $483.00M | $1.60B | $184.00M | $3.05B | $738.00M |
| Tax | $195.00M | $382.00M | $45.00M | $752.00M | $158.00M |
| Net Profit | $288.00M | $1.22B | $139.00M | $2.30B | $580.00M |
| Profit from Continuing Operations | $288.00M | $1.22B | $139.00M | $2.30B | $580.00M |
| Minority Interests | $4.00M | $8.00M | $8.00M | $30.00M | $9.00M |
| Net Income to Parent Company | $284.00M | $1.21B | $131.00M | $2.27B | $571.00M |
| Net Income to Common Stockholders | $284.00M | $1.21B | $131.00M | $2.27B | $571.00M |
| Basic EPS | $0.60 | $2.53 | $0.27 | $4.66 | $1.18 |
| Diluted EPS | $0.60 | $2.53 | $0.27 | $4.66 | $1.18 |
| Dividend Per Share | $0.55 | $0.55 | $0.55 | $2.18 | $0.55 |
| Non-Operating Interest Income | – | – | – | $51.00M | – |
| Total Other Finance Costs | – | – | – | $9.00M | – |
| -Less:Other Special Charges | – | – | – | -$1.00M | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $52.69B | $53.56B | $53.92B | $52.30B | $52.30B |
| Total Current Assets | $15.28B | $16.17B | $16.48B | $14.75B | $14.75B |
| Cash and Cash Equivalents & Short-Term Investments | $919.00M | $921.00M | $777.00M | $701.00M | $701.00M |
| -Cash and Cash Equivalents | $919.00M | $921.00M | $777.00M | $701.00M | $701.00M |
| Receivables | $8.22B | $8.69B | $6.28B | $5.68B | $5.68B |
| -Accounts Receivable | $8.22B | $8.69B | $6.28B | $5.08B | $5.08B |
| Inventory | $5.70B | $6.16B | $8.68B | $6.98B | $6.98B |
| Other Current Assets | $442.00M | $395.00M | $733.00M | $1.40B | $1.40B |
| Total Non-Current Assets | $37.42B | $37.39B | $37.45B | $37.55B | $37.55B |
| Net PPE | $22.78B | $22.67B | $22.66B | $22.75B | $22.75B |
| Investments and Advances | $136.00M | $137.00M | $146.00M | $144.00M | $144.00M |
| Goodwill and Other Intangible Assets | $13.67B | $13.74B | $13.80B | $13.80B | $13.80B |
| -Goodwill | $12.15B | $12.17B | $12.18B | $12.14B | $12.14B |
| -Other Intangible Assets | $1.52B | $1.57B | $1.62B | $1.67B | $1.67B |
| Other Non-Current Assets | $835.00M | $840.00M | $846.00M | $365.00M | $365.00M |
| Total Liabilities | $26.93B | $27.62B | $28.73B | $26.94B | $26.94B |
| Total Current Liabilities | $10.81B | $11.62B | $13.30B | $11.04B | $11.04B |
| Short-Term Debt and Capital Lease Obligation | $3.74B | $2.33B | $4.16B | $1.73B | $1.73B |
| -Current Debt | $3.39B | $1.96B | $3.80B | $1.39B | $1.39B |
| -Current Capital Lease Obligation | $348.00M | $366.00M | $362.00M | $346.00M | $346.00M |
| Total Non-Current Liabilities | $16.13B | $15.99B | $15.43B | $15.90B | $15.90B |
| Long Term Debt and Capital Lease Obligation | $10.38B | $10.40B | $9.78B | $10.29B | $10.29B |
| -Long Term Debt | $9.41B | $9.43B | $8.83B | $9.35B | $9.35B |
| -Long Term Capital Lease Obligation | $964.00M | $974.00M | $957.00M | $937.00M | $937.00M |
| Non-Current Liabilities | $1.47B | $1.45B | $1.48B | $1.47B | $1.47B |
| Non-Current Deferred Liabilities | $3.78B | $3.69B | $3.70B | $3.67B | $3.67B |
| Employee Benefits | $214.00M | $214.00M | $218.00M | $221.00M | $221.00M |
| Other Non-Current Liabilities | $285.00M | $245.00M | $251.00M | $253.00M | $253.00M |
| Total Equity | $25.76B | $25.94B | $25.19B | $25.37B | $25.37B |
| Stockholders' Equity | $25.72B | $25.90B | $25.15B | $25.32B | $25.32B |
| Capital Stock | $13.36B | $13.45B | $13.52B | $13.52B | $13.52B |
| -Common Stock | $13.36B | $13.45B | $13.52B | $13.52B | $13.52B |
| Additional Paid-In Capital | $52.00M | $51.00M | $49.00M | $57.00M | $57.00M |
| Retained Earnings | $12.58B | $12.69B | $11.85B | $12.08B | $12.08B |
| Gains/Losses Not Affecting Retained Earnings | -$266.00M | -$289.00M | -$263.00M | -$329.00M | -$329.00M |
| Minority Interests | $40.00M | $36.00M | $38.00M | $42.00M | $42.00M |
| -Taxes Receivable | – | – | – | $135.00M | $135.00M |
| -Other Receivables | – | – | – | $460.00M | $460.00M |
| -Gross PPE | – | – | – | $42.29B | $42.29B |
| -Accumulated Depreciation | – | – | – | -$19.54B | -$19.54B |
| -Available for Sale Securities | – | – | – | $10.00M | $10.00M |
| -Long Term Equity Investment | – | – | – | $134.00M | $134.00M |
| Non Current Accounts Receivables | – | – | – | $72.00M | $72.00M |
| Defined Pension Benefit | – | – | – | $145.00M | $145.00M |
| Non-Current Deferred Assets | – | – | – | $276.00M | $276.00M |
| Payables | – | – | – | $6.00B | $6.00B |
| -Accounts Payable | – | – | – | $5.54B | $5.54B |
| -Total Tax Payable | – | – | – | $99.00M | $99.00M |
| -Dividends Payable | – | – | – | $263.00M | $263.00M |
| -Other Payable | – | – | – | $94.00M | $94.00M |
| Current Accrued Expenses | – | – | – | $583.00M | $583.00M |
| Current Provisions | – | – | – | $208.00M | $208.00M |
| Current Deferred Liabilities | – | – | – | $1.83B | $1.83B |
| Other Current Liabilities | – | – | – | $8.00M | $8.00M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$425.00M | $2.48B | -$851.00M | $4.01B | $2.98B |
| Net cash flow from continuing operations | -$425.00M | $2.48B | -$851.00M | $4.01B | $2.98B |
| Net Income from Continuing Operations | $288.00M | $1.22B | $139.00M | $2.30B | $580.00M |
| Gain/Loss from Continuing Operations | $1.00M | -$1.00M | -$1.00M | -$236.00M | -$302.00M |
| Depreciation & Depletion & Amortization | $640.00M | $604.00M | $606.00M | $2.37B | $567.00M |
| Deferred Tax | $117.00M | -$16.00M | $26.00M | $185.00M | -$60.00M |
| Other Non-Cash Items | -$96.00M | $70.00M | $27.00M | $12.00M | $61.00M |
| Change in Working Capital | -$1.45B | $646.00M | -$1.76B | -$783.00M | $2.09B |
| -Change in Receivables | $487.00M | -$2.39B | -$530.00M | -$128.00M | $2.12B |
| -Change in Inventory | $382.00M | $2.91B | -$991.00M | -$557.00M | -$2.43B |
| -Change in Payables and Accrued Expense | -$2.32B | $122.00M | -$243.00M | -$98.00M | $2.40B |
| Net cash flow from investing | -$432.00M | -$505.00M | -$487.00M | -$1.37B | -$251.00M |
| Net Cash Flow from Continuing Investing Activities | -$432.00M | -$505.00M | -$487.00M | -$1.37B | -$251.00M |
| Capital Expenditure | -$525.00M | -$491.00M | -$325.00M | -$2.01B | -$751.00M |
| Net Business Purchase and Sale | $0.00 | $10.00M | -$50.00M | -$23.00M | -$11.00M |
| Net Investment Purchase and Sale | $5.00M | -$34.00M | -$8.00M | $711.00M | $450.00M |
| Net Other Investing Changes | $88.00M | $10.00M | -$104.00M | -$55.00M | $61.00M |
| Financing Cash Flow | $849.00M | -$1.82B | $1.43B | -$2.82B | -$2.66B |
| Net Cash Flow from Continuing Financing Activities | $849.00M | -$1.82B | $1.43B | -$2.82B | -$2.66B |
| Net Issuance Payments Of Debt | $1.34B | -$1.38B | $1.81B | -$1.21B | -$2.25B |
| Net Common Stock Issuance | -$223.00M | -$171.00M | -$102.00M | -$513.00M | -$141.00M |
| Cash Dividends Paid | -$263.00M | -$266.00M | -$262.00M | -$1.06B | -$263.00M |
| Net Other Financing Charges | -$3.00M | -$2.00M | -$22.00M | -$37.00M | -$3.00M |
| Ending Cash Balance | $919.00M | $921.00M | $777.00M | $701.00M | $701.00M |
| Net Change in Cash | -$8.00M | $157.00M | $88.00M | -$182.00M | $65.00M |
| Beginning Cash Balance | $921.00M | $777.00M | $688.00M | $853.00M | $624.00M |
| Effect of Exchange Rate Changes | $6.00M | -$13.00M | $1.00M | $30.00M | $12.00M |
| Free Cash Flow | -$950.00M | $1.99B | -$1.18B | $2.00B | $2.23B |
No comments yet — be the first to weigh in on NTR.
Sign in to join the discussion.